These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18923200)

  • 41. [Vaccination against cervical cancer and diseases caused by Human Papillomavirus].
    Bornstein J; Tuma R; Zarfati D; Ophir E
    Harefuah; 2007 Oct; 146(10):764-9, 814. PubMed ID: 17990391
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human papillomavirus quadrivalent vaccine: a look behind the numbers.
    Flaherty DK; Alkhateeb FM
    Ann Pharmacother; 2009 Apr; 43(4):740-4. PubMed ID: 19276314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Health economic evaluation of human papillomavirus vaccines in the developing countries: systematic reviews].
    Song X; Mao F; Zhou Z; Zhao Q; Fang Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jan; 50(1):85-90. PubMed ID: 26792509
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prophylactic human papillomavirus vaccination: a breakthrough in primary cervical cancer prevention.
    Garcia FA; Saslow D
    Obstet Gynecol Clin North Am; 2007 Dec; 34(4):761-81, ix. PubMed ID: 18061868
    [TBL] [Abstract][Full Text] [Related]  

  • 45. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors.
    Saslow D; Castle PE; Cox JT; Davey DD; Einstein MH; Ferris DG; Goldie SJ; Harper DM; Kinney W; Moscicki AB; Noller KL; Wheeler CM; Ades T; Andrews KS; Doroshenk MK; Kahn KG; Schmidt C; Shafey O; Smith RA; Partridge EE; ; Garcia F
    CA Cancer J Clin; 2007; 57(1):7-28. PubMed ID: 17237032
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Status of HPV vaccine introduction and barriers to country uptake.
    Gallagher KE; LaMontagne DS; Watson-Jones D
    Vaccine; 2018 Aug; 36(32 Pt A):4761-4767. PubMed ID: 29580641
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevention of human papillomavirus (HPV) infection and cervical cancer in China: how does HPV vaccination bring about benefits to Chinese women?
    Liu X; Feng A; Cui Y; Tobe RG
    Biosci Trends; 2013 Aug; 7(4):159-67. PubMed ID: 24056165
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The use of the human papillomavirus vaccine].
    Coquin Y; Guyot S; Le Quellec-Nathan M; Houssin D
    Rev Prat; 2006 Nov; 56(17):1861-2. PubMed ID: 17243380
    [No Abstract]   [Full Text] [Related]  

  • 49. Journey of the Human Papillomavirus (HPV) in a Developing Country over 5 Years (2010 - 2015).
    Danial M; Sivasangari S; Arulappen A; Ong L
    Asian Pac J Cancer Prev; 2016; 17(3):1363-8. PubMed ID: 27039773
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Should all women be vaccinated against HPV?
    Schmitt HJ; Kaufmann AM; Schneider A
    Pol Arch Med Wewn; 2007 Oct; 117(10):448-51. PubMed ID: 18320785
    [No Abstract]   [Full Text] [Related]  

  • 51. Human papillomavirus vaccines to prevent cervical cancer.
    Markman M
    Lancet; 2007 Jun; 369(9576):1837-1839. PubMed ID: 17544748
    [No Abstract]   [Full Text] [Related]  

  • 52. Debate begins over public funding for HPV vaccine.
    Comeau P
    CMAJ; 2007 Mar; 176(7):913-4. PubMed ID: 17374749
    [No Abstract]   [Full Text] [Related]  

  • 53. Development and impact of human papillomavirus vaccines.
    Darus CJ; Mueller JJ
    Clin Obstet Gynecol; 2013 Mar; 56(1):10-6. PubMed ID: 23314717
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Indications and efficacy of the human papillomavirus vaccine.
    Hakim AA; Lin PS; Wilczynski S; Nguyen K; Lynes B; Wakabayashi MT
    Curr Treat Options Oncol; 2007 Dec; 8(6):393-401. PubMed ID: 18172770
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HPV vaccines: too soon to detect an impact on mortality.
    Prescrire Int; 2016 Nov; 25(176):268. PubMed ID: 30730123
    [No Abstract]   [Full Text] [Related]  

  • 56. Pricing human papillomavirus vaccines: lessons from Italy.
    Garattini L; van de Vooren K; Curto A
    Pharmacoeconomics; 2012 Mar; 30(3):213-7. PubMed ID: 22233523
    [No Abstract]   [Full Text] [Related]  

  • 57. HPV vaccine trial may take place in India.
    Sharma DC
    Lancet Oncol; 2002 Nov; 3(11):649. PubMed ID: 12424057
    [No Abstract]   [Full Text] [Related]  

  • 58. Cervical cancer: screening and prevention.
    Behtash N; Mehrdad N
    Asian Pac J Cancer Prev; 2006; 7(4):683-6. PubMed ID: 17250453
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Awareness and attitude towards HPV and its vaccines among market women in Bodija Market, Ibadan.
    Bello OO; Oluwasola TAO; Odukogbe AA
    Niger J Med; 2016; 25(1):12-7. PubMed ID: 29963796
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [BENEFITS AND RISKS AT IMPLEMENTATION OF PROPHILACTIC VACCINES FOR CERVICAL CANCER].
    Zlatkov V; Kostova P
    Akush Ginekol (Sofiia); 2016; 55(3):28-33. PubMed ID: 27514142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.